In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Interested in acute cardiovascular care?

Watch webinars and videos, download presentations and read abstracts on ESC 365, the cardiology knowledge hub.

Access now

Case-based challenges and gaps of the 2019 ESC Guidelines on dyslipidaemias

Association for Acute CardioVascular Care Webinar

10/12/2020 18:00 10/12/2020 19:00 Europe/Paris Case-based challenges and gaps of the 2019 ESC Guidelines on dyslipidaemias

Access event page

Association for Acute CardioVascular Care DD/MM/YYYY
Association for Acute CardioVascular Care
Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care

Focus on

Learning objectives

After watching the webinar, participants will:

  • Understand the rationale of the new LDL cholesterol targets
  • Learn how to deal with applications of the new dyslipidaemia guidelines in daily practice
  • Learn about new trials evaluating PCSK9i in high and very high-risk patients
  • Learn about lipid management in primary and secondary prevention

Needs assessment and educational expected outcome:
The 2019 ESC Clinical Practice Guidelines on the management of dyslipidaemias recommend more stringent targets of LDL cholesterol for the prevention of vascular events. Particularly in patients with ACS, the target LDL is lowered to <55mg% and even <40mg% in a subgroup of patients with recurrent ischaemic events. It is clear that with standard statin treatment this goal will not be achieved in a substantial proportion of patients and especially in those who do not tolerate a high dose of statine. So, how to deal with this new situation and what are lipid management strategies for both primary and secondary prevention. The present webinar will address these issues.

Programme of the lectures : 

  • 1st case-based presentation, including MCQs by Prof. Peter Sinnaeve on “The new LDL cholesterol targets: a logical next step or still debatable?”
  • 2nd case-based presentation, including MCQs by Prof. Heinz Drexel on “Clinical applicability of new LDL cholesterol targets across the whole spectrum of patients (low-intermediate-high risk) including the safety of very low LDL levels”
  • 3rd case-based presentation, including MCQs on by Prof. Kausik K Ray “Management of LDLc in Europe: learnings from the DaVinci study”

Watch the webinar recording



sinnaeve-peter-2014.jpgProfessor Peter R Sinnaeve, FESC
University Of Leuven (Uz Gasthuisberg)
Leuven, Belgium

drexel-heinz.jpgProfessor Heinz Drexel, FESC
Academic Teaching Hospital Feldkirch
Feldkirch, Austria

Kausik K Ray.pngProfessor Kausik K Ray, FESC
Imperial College London
London, United Kingdom



Christian-Hassager.jpgProfessor Christian Hassager, FESC
Copenhagen, Denmark


Session information

This webinar is designed to cardiologists, intensivists and specialists in internal medicine wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

An application has been made to the EACCME® for CME accreditation of this event.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).